The prevalence of calcified carotid artery atheromas on the panoramic radiographs of patients with type 2 diabetes mellitus

Journal of the American Dental Association

Volumn 133, Issue 11, 2002, Pages 1516-1523

  Friedlander, Arthur H ^a,b   Garrett, Neal R ^c,d   Normam, Dean C ^d  

^a Aff Gtr Los Angeles Hlthcare S ^*  (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

AGED; ARTERIOSCLEROSIS; ARTICLE; CALCINOSIS; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; DIET; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANORAMIC RADIOGRAPHY; RADIOGRAPHY; RISK FACTOR;

AGED; ARTERIOSCLEROSIS; CALCINOSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIET; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RADIOGRAPHY, PANORAMIC; RISK FACTORS;

EID: 0036833952     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2002.0083     Document Type: Article

References (58)

1. Kanters SD, Banga JD, Stolk RP, Algra A. Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis. Vasc Med 1999;4(2):67-75.
2. Mogensen CE. Drug treatment for hypertensive patients in special situations: diabetes and hypertension. Clin Exp Hypertens 1999;21:895-906.
3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24.
4. Friedlander AH, Maeder LA. The prevalence of calcified carotid artery atheromas on the panoramic radiographs of patients with type 2 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:420-4.
5. Kapur KK, Garrett NR, Hamada MO, et al. A randomized clinical trial comparing the efficacy of mandibular implant-supported overdentures and conventional dentures in diabetic patients, part 1: methodology and clinical outcomes. J Prosth Dent 1998;79:555-69.
6. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
7. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
8. Friedlander AH. Panoramic radiography: the differential diagnosis of carotid atheromas. Spec Care Dentist 1995;15:223-7.
9. Farman TT, Chen Z, Khan Z, Friedlander AH, Carter LC, Farman AG. Image characteristics of digital panoramic radiography: potential for computer-aided diagnosis of calcified carotid artery atheromatous plaque. In: Lemke HU, Vannier MW, Inamura K, Farmen AG, Doi K, eds. CARS 2001: Proceedings of the 15th International Congress and Exhibition, Berlin, June 27-30, 2001. Amsterdam, Netherlands: Elsevier Science; 2001:485-9.
10. Hunter SJ, Garvey WT. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 1998;105:331-45.
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
12. Yki-Järvinen H. Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials. Drugs 2000;60:975-83.
13. Mudríková T, Szabová E, Tkac I. Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr 2000;112:887-91.
14. Grundy SM. Metabolic complications of obesity. Endocrine 2000;13(2):155-65.
15. Hart CL, Hole DJ, Smith GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke 1999;30:1999-2007.
16. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of middle-aged Finnish population. Stroke 1996;27:210-5.
17. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996;27(1):63-8.
18. Güvener N, Tütüncü NB, Oto A, Erbas T. Major determinants of the carotid intima-media thickness in type 2 diabetic patients: age and body mass index. Endocr J 2000;47:525-33.
19. Ahn CW, Lee HC, Park SW, et al. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes. Diabetes Res Clin Pract 2001;52(1):45-53.
20. Haffner SM, Agostino RD Jr, Saad MF, et al. Carotid artery atherosclerosis in type-2 and nondiabetic subjects with and without symptomatic coronary artery disease (the Insulin Resistance Atherosclerosis Study). Am J Cardiol 2000;85:1395-400.
21. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:713-20.
22. Moore WV, Fredrickson D, Brenner A, et al. Prevalence of hypertension in patients with type II diabetes in referral versus primary care clinics. J Diabetes Complications 1998;12:302-6.
23. UKPDS 34: effect of an intensive blood-glucose control policy with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998;352:854-65.
24. Oster G, Thompson D, Edelsberg J, Bird A, Colditz GA. Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health 1999;89:1536-42.
25. Sacco RL, Benjamin EJ, Broderick JP, et al. Risk factors. Stroke 1997;28:1507-17.
26. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000;13(1 Pt 2):3S-10S.
27. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12.
28. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000:321:412-9.
29. Uchimoto S, Tsumura K, Hayashi T, et al. Impact of cigarette smoking on the incidence of Type 2 diabetes mellitus in middle-aged Japanese men: the Osaka Health Survey. Diabet Med 1999;16:951-5.
30. Mikhailidis DP, Papadakis JA, Ganotakis ES. Smoking, diabetes and hyperlipidaemia. J R Soc Health 1998;118(2):91-3.
31. Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997;82:3619-24.
32. Kawamori R, Yamasaki Y, Matsushima H, et al. Prevalence of carotid atherosclerosis in diabetic patients, ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 1992;15:1290-4.
33. Shinozaki K, Naritomi H, Shimizu T, et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996;27(1):37-43.
34. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-17.
35. Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1998;21:1812-8.
36. Wannamethee SG, Perry IJ, Shaper AG. Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke 1999;30:1780-6.
37. Matsumoto K, Miyake S, Yano M, et al. Insulin resistance and classic risk factors in type 2 diabetic patients with subtypes of ischemic stroke. Diabetes Care 1999;22:1191-5.
38. Niskanen L, Turpeinen A, Penttila I, Uusitupa MI. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 1998;21:1861-9.
39. Kaukua J, Turpeinen A, Uusitupa M, Niskanen L. Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking. Diabetes Obes Metab 2001;3(1):17-23.
40. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 1999;22:333-8.
41. Witztum JL. Role of modified lipoproteins in diabetic macroangiopathy. Diabetes 1997;46(supplement 2):S112-4.
42. Morigi M, Angioletti S, Imberti B, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 1998;101:1905-15.
43. Joensuu T, Salonen R, Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 1994;236(1):79-84.
44. Pan WH, Bai CH, Chen JR, Chiu HC. Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension. Stroke 1997;28(1):88-94.
45. Yamamoto M, Egusa G, Yamakido M. Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM. Diabetes Care 1997;20:829-31.
46. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997;46(supplement 2):S19-25.
47. Chait A, Bierman EL. Pathogenesis of macrovascular disease in diabetes. In: Kahn CR, Weir GC, eds. Joslin's diabetes mellitus. 13th ed. Philadelphia: Lea & Febiger;1994:648-64.
48. Nesto RW, Libby P. Diabetes mellitus and the cardiovascular system. In: Braunwald E, Zipes DP, Libby P, ed. Heart disease: A textbook of cardiovascular medicine. 6th ed. Philadelphia: Saunders; 2001:2133-46.
49. Crouse JR 3rd. Heart of the matter in cerebral arterial sclerosis. Lancet 1996;348:776.
50. Cohen SN, Friedlander AH, Jolly DA, Date L, Reddy D, Kanakar P. Extracranial carotid calcification on panoramic dental radiographs: an important marker for vascular disease risk. Neurology 2001;56(supplement 2):50.
51. Chimowitz MI, Weiss DG, Cohen SL, Starling MR, Hobson RW 2nd. Cardiac prognosis of patients with carotid stenosis and no history of coronary artery disease. Stroke 1994;25:759-65.
52. Friedlander AH, Baker JD. Panoramic radiography: an aid in detecting patients at risk of a cerebrovascular accident. JADA 1994;125:1598-603.
53. Grimes RM, Richards E, Flaitz CM. Avoiding malpractice for non-dental conditions: the example of human immunodeficiency virus. JADA 2001;132:499-507.
54. Spanheimer RG. Reducing cardiovascular risk in diabetes: which factors to modify first? Postgrad Med 2001;109(4):26-36.
55. Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
56. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-8.
57. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997;46(supplement 2):S101-3.
58. Kalra L, Perez I, Melbourn A. Stroke risk management: changes in mainstream practice. Stroke 1998;29(1):53-7.